Saamya Biotech (India) Limited announced audited earnings results for the fourth quarter and year ended March 31, 2013. For the quarter, the company reported net loss of INR 2,326,999 or INR 0.09 basic and diluted loss per share after extra ordinary items on net sales/income from operations of compared to net loss of INR 496,998 or INR 0.02 basic and diluted loss per share after extra ordinary items on net sales/income from operations of for the corresponding period last year. Loss from ordinary activities before tax was INR 2,424,589 against INR 665,798 for the same period last year. Loss from operations before other income, interest & exceptional items was INR 2,467,304 against profit from operations of INR 673,442 of prior year period.

For the year, the company reported net loss of INR 3,999,351 or INR 0.16 basic and diluted loss per share after extra ordinary items on net sales/income from operations of compared to net profit of INR 2,786,789 or INR 0.11 basic and diluted earnings per share after extra ordinary items on net sales/income from operations of for the corresponding period last year. Loss from ordinary activities before tax was INR 4,064,506 against profit from ordinary activities before tax of INR 3,540,212 for the same period last year. Loss from operations before other income, interest & exceptional items was INR 3,881,166 against INR 2,888,035 of prior year period.